Jürgen C. Becker received his medical degree from the Medical School Hannover for his work on the immune regulatory capacity of natural killer cells on the adaptive immune system. After finishing medical school he was first trained in Dermatology at the University of Würzburg and then as well in Tumor Immunology at the Scripps Research Institute, La Jolla, and the Danish Cancer Society, Copenhagen. For his characterization of the impact of therapeutic interventions on the adaptive immune responses against melanoma in preclinical models he received the PhD in Immunology. In 2003 he became full professor for Dermato-Oncology in Würzburg, where he coordinated a Clinical Research Group focusing on the tumor microenvironment. In 2010, he was appointed as director of General Dermatology at the Medical University of Graz. There, in parallel to his clinical duties, he successfully attracted the FP7 EU-project IMMOMEC (IMmune MOdulating strategies for treatment of MErkel cell Carcinoma, www.immomec.eu), which he coordinates, and became deputy speaker of the graduate training program DK-MOLIN (Doktoratskolleg MOLecular fundamentals of INflammation, ). In September 2014, he joined the German Cancer Consortium (DKTK) and now is head of the Institute for Translation Skin Cancer Research (TSCR) within the the West German Cancer Center at the University Hospital Essen (www.unidue.de/zmb/members/becker/).
His research interests focus on the reciprocal effects of tumor and host cells, and more recently external factors such as bacteria (e.g. in cutaneous squamous cell carcinoma; cSCC) and viruses (e.g. in Merkel cell carcinoma; MCC) as well as the identification of prognostic and predictive biomarkers (e.g. for immune modulating therapy in melanoma).